Inizio (Group)

https://www.inizio.health

Uniting the expertise and capabilities of Ashfield and Huntsworth, Inizio is a strategic partner for companies in health and life sciences. Connecting a full suite of advisory, medical, marketing, communications and patient and stakeholder engagement services across the lifecycle of a drug, Inizio supports its partners from initial assessment to loss of exclusivity. Inizio has five specialist business units, each comprising of best-in-class companies that provide the depth, breadth and scale to activate transformational change and reimagine health. Inizio is backed by Clayton, Dubilier & Rice (CD&R). *

	Start	2022-06-30 merged
	Industry	public relations / investor relations / marcom (services)
	Industry 2	HEALTH (HUMAN)
	Person	Taaffe, Paul (Huntsworth 201903 CEO)
	Person 2	Quigley, Ryan (Inizio 202206 COO)

	Region	London, Greater London
	Country	United Kingdom (GB)
	Street	26 Southampton Buildings Holborn Gate, 8th Floor
	City	WC2A 1AN London
	Tel	+44-20-3861-3999
		Address record changed: 2022-07-05

Basic data	Employees	H: 10,001 to 50,00 (2022-12-31)
	Currency	USD
	Annual sales	2,101,563,000 (revenue, annual, consolidated (2022) 2022-12-31)
	Profit	-416,440,000 (2022-12-31)
	Cash	78,769,000 (2022-12-31)

		* Document for »About Section«: Inizio (trading name of CD&R Artemis Holdco 0.5 Ltd.). (6/30/22). "Press Release: Introducing Inizio. Ashfield and Huntsworth Unite Expertise to Form Powerful Strategic Partner for Health and Life Sciences Companies".

		Record changed: 2023-11-11